A Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution

Archive ouverte

Heitzmann, Edwige | Javelot, Hervé | Weiner, Luisa | Michel, Bruno

Edité par CCSD -

Aripiprazole is reported to be a good clinical safety profile antipsychotic. However, recent data suggest that the risk of tardive dyskinesia could be higher than initially thought. We report the case of aripiprazole-induced tardive dyskinesia with dramatic evolution in a patient with several risk factors, including older age and exposure to antipsychotic over a period longer than six months. This case and its dramatic evolution, associated with other cases recently published, suggest reconsidering the real risk of tardive dyskinesia associated with aripiprazole, particularly in the elderly.

Suggestions

Du même auteur

L’échelle d’imprégnation anticholinergique : vers l’élaboration d’une échelle adaptée aux prescriptions en milieu psychiatrique français [The anticholinergic impregnation scale: Towards the elaboration of a scale adapted to prescriptions in French psychiatric settings]

Archive ouverte | Briet, Jeanne | CCSD

Dyskinésie de retrait induite par la quétiapine : à propos d’un cas

Archive ouverte | Javelot, Hervé | CCSD

Augmentation de l’intervalle QT imputable à un traitement antiandrogénique, majorée par les psychotropes : à propos d’un cas [Increased QT interval due to antiandrogenic therapy, majorated by psychotropic drugs: About one case]

Archive ouverte | Heitzmann, Edwige | CCSD

Chargement des enrichissements...